Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Green healthcare.

Lakhan SE.

Medscape J Med. 2008;10(8):192; author reply 192. Epub 2008 Aug 14. No abstract available.

2.

Green healthcare--why not?

Yellowlees P.

Medscape J Med. 2008 Jul 7;10(7):157. No abstract available.

3.

Green healthcare: what does the future hold?

Yellowlees P.

Medscape J Med. 2008 Jul 14;10(7):163. No abstract available.

4.

Green healthcare: what is happening now?

Yellowlees P.

Medscape J Med. 2008 Jul 11;10(7):162. No abstract available.

5.

Time to rebuild Iraq.

[No authors listed]

Med Device Technol. 2003 Jun;14(5):34. No abstract available.

PMID:
12852122
6.

China commits itself to biotech in healthcare.

Kermani F, Zhou Y.

Drug Discov Today. 2007 Jul;12(13-14):501-3. Epub 2007 Jun 27. No abstract available.

PMID:
17631243
7.

Clinical ethics and the managerial revolution in American healthcare.

Mills AE, Rorty MV, Werhane PH.

J Clin Ethics. 2006 Summer;17(2):181-90. No abstract available.

PMID:
16913153
8.

Is this where we want to go?

MacPherson P.

Hastings Cent Rep. 1997 Nov-Dec;27(6):17-22. No abstract available.

PMID:
9474490
9.

Achieving better healthcare through diverse leadership. Interview by Mari Paul.

Ramamoorthy P.

Nat Biotechnol. 2011 Jul 11;29(7):665-6. doi: 10.1038/nbt.1916. No abstract available.

PMID:
21747389
10.

The four habits of high-value health care organizations.

Bohmer RM.

N Engl J Med. 2011 Dec 1;365(22):2045-7. doi: 10.1056/NEJMp1111087. No abstract available.

11.

State of the industry.

Basu PA.

J Am Coll Radiol. 2013 Oct;10(10):727-9. doi: 10.1016/j.jacr.2013.05.035. Epub 2013 Aug 15. No abstract available.

PMID:
23953897
12.

Understanding the complexity of the U.S. health care system: can free-market ideology respond to a current challenge?

Gunnar WP.

Perspect Biol Med. 2008 Winter;51(1):149-54. No abstract available.

PMID:
18320696
13.

Health biotechnology in China--reawakening of a giant.

Zhenzhen L, Jiuchun Z, Ke W, Thorsteinsdóttir H, Quach U, Singer PA, Daar AS.

Nat Biotechnol. 2004 Dec;22 Suppl:DC13-8. No abstract available.

PMID:
15583678
14.

South Africa--blazing a trail for African biotechnology.

Motari M, Quach U, Thorsteinsdóttir H, Martin DK, Daar AS, Singer PA.

Nat Biotechnol. 2004 Dec;22 Suppl:DC37-41. No abstract available.

PMID:
15583683
15.

Co-opetition: the new market milieu.

Gee EP.

J Healthc Manag. 2000 Nov-Dec;45(6):359-63. No abstract available.

PMID:
11187357
16.

Indian biotechnology--rapidly evolving and industry led.

Kumar NK, Quach U, Thorsteinsdóttir H, Somsekhar H, Daar AS, Singer PA.

Nat Biotechnol. 2004 Dec;22 Suppl:DC31-6. No abstract available.

PMID:
15583682
17.

Health sector reform and the Health Management Reform Project in Fiji.

Rokovada L.

P N G Med J. 2006 Sep-Dec;49(3-4):87-92. No abstract available.

PMID:
18389963
18.

The scientific muscle of Brazil's health biotechnology.

Ferrer M, Thorsteinsdóttir H, Quach U, Singer PA, Daar AS.

Nat Biotechnol. 2004 Dec;22 Suppl:DC8-12. No abstract available.

PMID:
15583686
19.

Conclusions: promoting biotechnology innovation in developing countries.

Thorsteinsdóttir H, Quach U, Daar AS, Singer PA.

Nat Biotechnol. 2004 Dec;22 Suppl:DC48-52. No abstract available.

PMID:
15583685
20.

South Korean biotechnology--a rising industrial and scientific powerhouse.

Wong J, Quach U, Thorsteinsdóttir H, Singer PA, Daar AS.

Nat Biotechnol. 2004 Dec;22 Suppl:DC42-7. No abstract available.

PMID:
15583684

Supplemental Content

Support Center